Developed through a strategic partnership with Trilogene Seeds, this variety combines the best traits of CBD and CBDV, offering new possibilities for growers, researchers, and consumers alike. CBDV (cannabidivarin) is a minor cannabinoid that has recently gained attention for its potential therapeutic benefits.

With a cannabinoid profile of 1:1 CBD to CBDV, and maintaining total THC levels below 0.3%, this feminized hemp variety has shown exceptional performance in field trials, with robust yields and a stable cannabinoid profile, making it an ideal choice for large-scale cultivation.

Vendetta is now be available to licensed hemp growers in Canada as feminized seed starting in Spring 2025, and biomass will be made available to commercial processors in Fall 2025 exclusively through Cannabis Orchards. ​